Terazosin Does Not Cause Bradycardia
Terazosin, an alpha-1 adrenergic blocker, does not cause bradycardia and is not associated with heart rate reduction. In fact, the primary cardiovascular adverse effects of terazosin are hypotension and reflex tachycardia, not bradycardia.
Mechanism and Cardiovascular Effects
Terazosin works by selectively blocking alpha-1 adrenergic receptors, causing vasodilation and reduced peripheral vascular resistance. This mechanism differs fundamentally from drugs that cause bradycardia (such as beta-blockers or calcium channel blockers like verapamil and diltiazem) 1, 2.
The FDA drug label for terazosin explicitly lists tachycardia (increased heart rate) as an adverse effect, not bradycardia 3. In clinical trials:
- Tachycardia occurred in 1.9% of terazosin-treated patients versus 1.2% on placebo
- Syncope and hypotension were the primary concerns, particularly with first-dose administration
- No bradycardia was reported as an adverse effect 3
Clinical Evidence
Research studies consistently demonstrate that terazosin either maintains heart rate or may cause slight increases:
- A large megastudy of 16,917 hypertensive patients showed terazosin produced significant blood pressure reductions "without causing a significant increase in heart rate" 4
- Hemodynamic studies in heart failure patients showed terazosin improved cardiac parameters "without an increase in heart rate" 5
- Acute hemodynamic testing demonstrated "cardiac output, heart rate, and maximum left ventricular dp/dt demonstrated little change" with terazosin administration 6
Important Clinical Distinction
The confusion may arise because:
Beta-blockers that also block alpha-1 receptors (like carvedilol) can cause bradycardia, but this is due to their beta-blocking properties, not alpha-1 blockade 1, 2. The guidelines specifically note that "beta-blockers, especially those that also block alpha-1-receptors, can produce hypotension" but attribute bradycardia to the beta-blocking component 1, 2.
Drugs That Actually Cause Bradycardia
For context, medications that genuinely cause bradycardia include 7, 8, 9:
- Beta-blockers (propranolol, metoprolol, carvedilol, atenolol)
- Non-dihydropyridine calcium channel blockers (verapamil, diltiazem)
- Digoxin
- Certain antiarrhythmic drugs
Terazosin is not listed among drugs causing bradycardia in any major cardiovascular guidelines 7, 8, 9.
Clinical Implications
When prescribing terazosin for benign prostatic hyperplasia or hypertension 10:
- Monitor for orthostatic hypotension and dizziness, not bradycardia
- Start with 1 mg at bedtime to minimize first-dose syncope risk 3
- The primary cardiovascular concern is excessive blood pressure lowering, particularly postural hypotension
- Heart rate monitoring for bradycardia is not indicated unless the patient is on concomitant medications that affect heart rate